GLP-1 receptor agonists are medications that help regulate blood sugar, reduce appetite, and support weight loss by slowing how quickly food moves through your digestive system. They work by mimicking a hormone your body naturally produces to help control hunger and fullness.

Our physicians evaluate candidates based on BMI, medical history, and weight loss goals. Generally, candidates have a BMI of 27+ with weight-related health conditions. A thorough medical evaluation determines eligibility.

Some of the more common side effects include:

Nausea, Vomiting, Diarrhea.

Side effects can often be mitigated by correctly titrating your dosage upward, so you’ll want to ensure that you are taking the medication exactly as prescribed by your provider to minimize risk and/or severity of side effects. Anti-nausea medications such as ondansetron (generic Zofran) are also helpful to assist in

mitigating nausea.

Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of drugs. But the risk of low blood sugar levels often only goes up if you’re also taking another drug known to lower blood sugar at the same time, such as sulfonylureas or insulin. The GLP-1 class of drugs isn’t recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia. Lab studies have linked these drugs with thyroid tumors in rats. But until more long-term studies are done, the risk to humans isn’t known. The GLP-1 class of drugs is also not recommended if you’ve had pancreatitis.

Clinical studies show average weight loss of 12-22% of body weight over 68 weeks, though individual results vary. Your physician will set realistic expectations based on your specific situation and health profile.

Our GLP-1 programs start at $249 per month, which includes physician consultations, medication, and ongoing support. We provide transparent pricing with no hidden fees before you begin treatment.